

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.36710445 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.39024013 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 6.39024013 |
| 4 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.09708551 |
| 5 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.09708551 |
| 6 | NADH dehydrogenase complex assembly (GO:0010257) | 5.09708551 |
| 7 | platelet dense granule organization (GO:0060155) | 5.03665824 |
| 8 | DNA strand renaturation (GO:0000733) | 4.98052766 |
| 9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.80575299 |
| 10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.80232059 |
| 11 | cullin deneddylation (GO:0010388) | 4.52165235 |
| 12 | blood vessel maturation (GO:0001955) | 4.52100910 |
| 13 | chaperone-mediated protein transport (GO:0072321) | 4.51351068 |
| 14 | protein complex biogenesis (GO:0070271) | 4.43904927 |
| 15 | respiratory electron transport chain (GO:0022904) | 4.43840237 |
| 16 | electron transport chain (GO:0022900) | 4.33653295 |
| 17 | proteasome assembly (GO:0043248) | 4.23685682 |
| 18 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 4.13371399 |
| 19 | regulation of mitotic spindle checkpoint (GO:1903504) | 4.13371399 |
| 20 | respiratory chain complex IV assembly (GO:0008535) | 3.99360725 |
| 21 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.98154138 |
| 22 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.89931259 |
| 23 | protein deneddylation (GO:0000338) | 3.81947882 |
| 24 | establishment of integrated proviral latency (GO:0075713) | 3.81665151 |
| 25 | nucleotide transmembrane transport (GO:1901679) | 3.77074356 |
| 26 | viral mRNA export from host cell nucleus (GO:0046784) | 3.74519974 |
| 27 | cytochrome complex assembly (GO:0017004) | 3.59555784 |
| 28 | ATP biosynthetic process (GO:0006754) | 3.58533142 |
| 29 | aldehyde catabolic process (GO:0046185) | 3.56681864 |
| 30 | phagocytosis, recognition (GO:0006910) | 3.53500118 |
| 31 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.52704540 |
| 32 | signal peptide processing (GO:0006465) | 3.52133832 |
| 33 | DNA damage response, detection of DNA damage (GO:0042769) | 3.49821246 |
| 34 | GMP metabolic process (GO:0046037) | 3.48097805 |
| 35 | regulation of T cell chemotaxis (GO:0010819) | 3.47516126 |
| 36 | positive regulation of T cell chemotaxis (GO:0010820) | 3.47516126 |
| 37 | establishment of viral latency (GO:0019043) | 3.45115555 |
| 38 | hydrogen ion transmembrane transport (GO:1902600) | 3.41622629 |
| 39 | protein neddylation (GO:0045116) | 3.39920042 |
| 40 | ER overload response (GO:0006983) | 3.38527818 |
| 41 | multicellular organism reproduction (GO:0032504) | 3.37281241 |
| 42 | female mating behavior (GO:0060180) | 3.36619167 |
| 43 | L-fucose metabolic process (GO:0042354) | 3.35632945 |
| 44 | L-fucose catabolic process (GO:0042355) | 3.35632945 |
| 45 | fucose catabolic process (GO:0019317) | 3.35632945 |
| 46 | inner mitochondrial membrane organization (GO:0007007) | 3.34975510 |
| 47 | organelle membrane fusion (GO:0090174) | 3.34733577 |
| 48 | regulation of RIG-I signaling pathway (GO:0039535) | 3.34328199 |
| 49 | multicellular organismal aging (GO:0010259) | 3.33254899 |
| 50 | oxidative phosphorylation (GO:0006119) | 3.32889599 |
| 51 | adaptation of signaling pathway (GO:0023058) | 3.31450944 |
| 52 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.30928267 |
| 53 | proton transport (GO:0015992) | 3.29818963 |
| 54 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.28496292 |
| 55 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.27348488 |
| 56 | protein peptidyl-prolyl isomerization (GO:0000413) | 3.25548641 |
| 57 | hydrogen transport (GO:0006818) | 3.23217680 |
| 58 | macrophage differentiation (GO:0030225) | 3.21720439 |
| 59 | endosome to pigment granule transport (GO:0043485) | 3.21119710 |
| 60 | endosome to melanosome transport (GO:0035646) | 3.21119710 |
| 61 | positive regulation of prostaglandin secretion (GO:0032308) | 3.20458628 |
| 62 | regulation of cilium movement (GO:0003352) | 3.20290461 |
| 63 | acrosome reaction (GO:0007340) | 3.20287561 |
| 64 | rRNA modification (GO:0000154) | 3.12461283 |
| 65 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03935690 |
| 66 | neuromuscular synaptic transmission (GO:0007274) | 3.02169933 |
| 67 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.97265428 |
| 68 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.94734536 |
| 69 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.93889158 |
| 70 | protein localization to mitochondrion (GO:0070585) | 2.92051033 |
| 71 | protein polyglutamylation (GO:0018095) | 2.90727079 |
| 72 | response to pheromone (GO:0019236) | 2.90029334 |
| 73 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.86241763 |
| 74 | negative regulation of meiosis (GO:0045835) | 2.84623581 |
| 75 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84238019 |
| 76 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.83510140 |
| 77 | protein targeting to mitochondrion (GO:0006626) | 2.82188226 |
| 78 | behavioral response to nicotine (GO:0035095) | 2.79245340 |
| 79 | negative regulation of telomere maintenance (GO:0032205) | 2.79169325 |
| 80 | histone mRNA metabolic process (GO:0008334) | 2.78132509 |
| 81 | termination of RNA polymerase III transcription (GO:0006386) | 2.77912534 |
| 82 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.77912534 |
| 83 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.76752474 |
| 84 | peptidyl-proline modification (GO:0018208) | 2.76450508 |
| 85 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.75750796 |
| 86 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.75750796 |
| 87 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.68759796 |
| 88 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.67740255 |
| 89 | fucose metabolic process (GO:0006004) | 2.67016398 |
| 90 | cytokine biosynthetic process (GO:0042089) | 2.67005922 |
| 91 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.66128582 |
| 92 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.66128582 |
| 93 | establishment of protein localization to mitochondrion (GO:0072655) | 2.65174794 |
| 94 | short-chain fatty acid metabolic process (GO:0046459) | 2.64368052 |
| 95 | anterograde synaptic vesicle transport (GO:0048490) | 2.62202033 |
| 96 | regulation of protein kinase A signaling (GO:0010738) | 2.61445995 |
| 97 | activation of adenylate cyclase activity (GO:0007190) | 2.60217171 |
| 98 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.59994132 |
| 99 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.59994132 |
| 100 | base-excision repair, AP site formation (GO:0006285) | 2.59516941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.53829968 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.60153631 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.27275285 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.24629034 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.66333582 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.57749531 |
| 7 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.42571009 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.25174700 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95409811 |
| 10 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.87338516 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.31213057 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.24960487 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.18405400 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.18034750 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10615633 |
| 16 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.08950372 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.05500894 |
| 18 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.00938887 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.91816637 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.82226871 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.74087796 |
| 22 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68971225 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.64796828 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62923811 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60781305 |
| 26 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.57463037 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57390204 |
| 28 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.56144755 |
| 29 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.52167471 |
| 30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.51021104 |
| 31 | EWS_26573619_Chip-Seq_HEK293_Human | 1.46106951 |
| 32 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.44945447 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.44907425 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.43091621 |
| 35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41201106 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35693221 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35606274 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.35500847 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31622614 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31471026 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.30071491 |
| 42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29751301 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27079624 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27071200 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25854684 |
| 46 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24665338 |
| 47 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21564214 |
| 48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19234661 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18783919 |
| 50 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17067036 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14303625 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.14196053 |
| 53 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10996166 |
| 54 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.10685737 |
| 55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.10560561 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08244931 |
| 57 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07309041 |
| 58 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.06549722 |
| 59 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06011553 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05552089 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05438983 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03702761 |
| 63 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03067895 |
| 64 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.02486117 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01060471 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99825186 |
| 67 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99452399 |
| 68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97625390 |
| 69 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97143636 |
| 70 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96057128 |
| 71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95247954 |
| 72 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.93038297 |
| 73 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.93038297 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92914707 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91545765 |
| 76 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.90882924 |
| 77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89682384 |
| 78 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.89670656 |
| 79 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.88798306 |
| 80 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86744927 |
| 81 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86613240 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.84821888 |
| 83 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.84821888 |
| 84 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.84549163 |
| 85 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.84397409 |
| 86 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.83237057 |
| 87 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.83200717 |
| 88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82001497 |
| 89 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81629464 |
| 90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81500460 |
| 91 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.81491652 |
| 92 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.81256824 |
| 93 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81151409 |
| 94 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.80424537 |
| 95 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80128802 |
| 96 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.79722480 |
| 97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79437508 |
| 98 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79356804 |
| 99 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79320349 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78737117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.33832593 |
| 2 | MP0006054_spinal_hemorrhage | 4.31933616 |
| 3 | MP0000372_irregular_coat_pigmentation | 3.79344080 |
| 4 | MP0004147_increased_porphyrin_level | 3.31229083 |
| 5 | MP0000015_abnormal_ear_pigmentation | 2.93343566 |
| 6 | MP0005174_abnormal_tail_pigmentation | 2.63827111 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.55023660 |
| 8 | MP0009379_abnormal_foot_pigmentation | 2.45946094 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.42362573 |
| 10 | MP0003283_abnormal_digestive_organ | 2.42262667 |
| 11 | MP0003787_abnormal_imprinting | 2.41349261 |
| 12 | MP0003011_delayed_dark_adaptation | 2.40182185 |
| 13 | MP0001529_abnormal_vocalization | 2.24917070 |
| 14 | MP0005310_abnormal_salivary_gland | 2.23575958 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.14701524 |
| 16 | MP0003315_abnormal_perineum_morphology | 2.11821662 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.03121064 |
| 18 | MP0005187_abnormal_penis_morphology | 2.02453483 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 1.98703700 |
| 20 | MP0005360_urolithiasis | 1.89252097 |
| 21 | MP0003195_calcinosis | 1.81886651 |
| 22 | MP0000749_muscle_degeneration | 1.81871251 |
| 23 | MP0003186_abnormal_redox_activity | 1.78768890 |
| 24 | MP0004142_abnormal_muscle_tone | 1.77577412 |
| 25 | MP0001984_abnormal_olfaction | 1.70165168 |
| 26 | MP0000383_abnormal_hair_follicle | 1.64530502 |
| 27 | MP0003880_abnormal_central_pattern | 1.61934908 |
| 28 | MP0002095_abnormal_skin_pigmentation | 1.61293315 |
| 29 | MP0004510_myositis | 1.59558788 |
| 30 | MP0004043_abnormal_pH_regulation | 1.57863305 |
| 31 | MP0002751_abnormal_autonomic_nervous | 1.55892830 |
| 32 | MP0003868_abnormal_feces_composition | 1.54474432 |
| 33 | MP0008058_abnormal_DNA_repair | 1.54197559 |
| 34 | MP0005451_abnormal_body_composition | 1.52221202 |
| 35 | MP0002090_abnormal_vision | 1.51388878 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.49380721 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.48877229 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.47451325 |
| 39 | MP0005253_abnormal_eye_physiology | 1.44567677 |
| 40 | MP0005408_hypopigmentation | 1.42669707 |
| 41 | MP0009046_muscle_twitch | 1.40464480 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.37297972 |
| 43 | MP0001851_eye_inflammation | 1.31805124 |
| 44 | MP0008877_abnormal_DNA_methylation | 1.29895971 |
| 45 | MP0009745_abnormal_behavioral_response | 1.29325596 |
| 46 | MP0005410_abnormal_fertilization | 1.27958652 |
| 47 | MP0002163_abnormal_gland_morphology | 1.26622999 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.25698779 |
| 49 | MP0004484_altered_response_of | 1.25601055 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 1.24245554 |
| 51 | MP0003718_maternal_effect | 1.12868174 |
| 52 | MP0002938_white_spotting | 1.12514802 |
| 53 | MP0000358_abnormal_cell_content/ | 1.10794895 |
| 54 | MP0002254_reproductive_system_inflammat | 1.07316567 |
| 55 | MP0002272_abnormal_nervous_system | 1.06161222 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.06111254 |
| 57 | MP0001879_abnormal_lymphatic_vessel | 1.04740704 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 1.01934239 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.01532135 |
| 60 | MP0000647_abnormal_sebaceous_gland | 0.97084722 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.95135351 |
| 62 | MP0008872_abnormal_physiological_respon | 0.94903765 |
| 63 | MP0002108_abnormal_muscle_morphology | 0.93106755 |
| 64 | MP0003633_abnormal_nervous_system | 0.89314029 |
| 65 | MP0004742_abnormal_vestibular_system | 0.87677275 |
| 66 | MP0002184_abnormal_innervation | 0.86031691 |
| 67 | MP0006072_abnormal_retinal_apoptosis | 0.80489005 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 0.78561751 |
| 69 | MP0004215_abnormal_myocardial_fiber | 0.78094508 |
| 70 | MP0002064_seizures | 0.76695232 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 0.75237981 |
| 72 | MP0002269_muscular_atrophy | 0.72216311 |
| 73 | MP0002735_abnormal_chemical_nociception | 0.72035475 |
| 74 | MP0000613_abnormal_salivary_gland | 0.71994565 |
| 75 | MP0008007_abnormal_cellular_replicative | 0.71339982 |
| 76 | MP0002067_abnormal_sensory_capabilities | 0.70383800 |
| 77 | MP0005395_other_phenotype | 0.69912200 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.69489607 |
| 79 | MP0005503_abnormal_tendon_morphology | 0.69291192 |
| 80 | MP0009697_abnormal_copulation | 0.68239186 |
| 81 | MP0003646_muscle_fatigue | 0.67971893 |
| 82 | MP0001756_abnormal_urination | 0.66540803 |
| 83 | MP0008057_abnormal_DNA_replication | 0.66176736 |
| 84 | MP0000538_abnormal_urinary_bladder | 0.64502916 |
| 85 | MP0005266_abnormal_metabolism | 0.64355883 |
| 86 | MP0005165_increased_susceptibility_to | 0.64135730 |
| 87 | MP0005387_immune_system_phenotype | 0.63796493 |
| 88 | MP0001790_abnormal_immune_system | 0.63796493 |
| 89 | MP0001324_abnormal_eye_pigmentation | 0.63520214 |
| 90 | MP0005645_abnormal_hypothalamus_physiol | 0.63104065 |
| 91 | MP0002006_tumorigenesis | 0.62776857 |
| 92 | MP0005171_absent_coat_pigmentation | 0.62702073 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 0.61729614 |
| 94 | MP0002736_abnormal_nociception_after | 0.61222894 |
| 95 | MP0002148_abnormal_hypersensitivity_rea | 0.60399461 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.60349409 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.60037521 |
| 98 | MP0004924_abnormal_behavior | 0.60037521 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.59252223 |
| 100 | MP0010678_abnormal_skin_adnexa | 0.54459772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatocellular necrosis (HP:0001404) | 5.66789483 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.54192051 |
| 3 | Acute encephalopathy (HP:0006846) | 5.46486646 |
| 4 | Mitochondrial inheritance (HP:0001427) | 5.32467166 |
| 5 | Hepatic necrosis (HP:0002605) | 4.85145360 |
| 6 | Increased CSF lactate (HP:0002490) | 4.74430845 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.72335776 |
| 8 | Progressive macrocephaly (HP:0004481) | 4.41839989 |
| 9 | Congenital stationary night blindness (HP:0007642) | 4.11677516 |
| 10 | Muscle fiber atrophy (HP:0100295) | 4.07847017 |
| 11 | Abnormality of the labia minora (HP:0012880) | 4.03730256 |
| 12 | Type 2 muscle fiber atrophy (HP:0003554) | 3.94791098 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 3.58788436 |
| 14 | Respiratory failure (HP:0002878) | 3.40392524 |
| 15 | Cerebral edema (HP:0002181) | 3.40284637 |
| 16 | Abnormal hair whorl (HP:0010721) | 3.24588694 |
| 17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.20645542 |
| 18 | Colon cancer (HP:0003003) | 3.20377139 |
| 19 | Limb dystonia (HP:0002451) | 3.18585243 |
| 20 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.87220695 |
| 21 | Pancreatic cysts (HP:0001737) | 2.85880107 |
| 22 | Medial flaring of the eyebrow (HP:0010747) | 2.82915826 |
| 23 | Constricted visual fields (HP:0001133) | 2.80067680 |
| 24 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.79639392 |
| 25 | Emotional lability (HP:0000712) | 2.79213502 |
| 26 | Optic disc pallor (HP:0000543) | 2.78232766 |
| 27 | Increased serum lactate (HP:0002151) | 2.77386039 |
| 28 | Poor suck (HP:0002033) | 2.75219180 |
| 29 | Abnormality of the anterior horn cell (HP:0006802) | 2.71384183 |
| 30 | Degeneration of anterior horn cells (HP:0002398) | 2.71384183 |
| 31 | Aplastic anemia (HP:0001915) | 2.64032720 |
| 32 | Lactic acidosis (HP:0003128) | 2.63702860 |
| 33 | Abnormality of midbrain morphology (HP:0002418) | 2.49637975 |
| 34 | Molar tooth sign on MRI (HP:0002419) | 2.49637975 |
| 35 | Decreased central vision (HP:0007663) | 2.48312085 |
| 36 | Hypothermia (HP:0002045) | 2.47927489 |
| 37 | Parakeratosis (HP:0001036) | 2.47539096 |
| 38 | Pancreatic fibrosis (HP:0100732) | 2.46520699 |
| 39 | Conjunctival telangiectasia (HP:0000524) | 2.39243407 |
| 40 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.37476943 |
| 41 | CNS demyelination (HP:0007305) | 2.32938116 |
| 42 | Weak cry (HP:0001612) | 2.31981713 |
| 43 | Congenital primary aphakia (HP:0007707) | 2.31524499 |
| 44 | Lipid accumulation in hepatocytes (HP:0006561) | 2.30525203 |
| 45 | Leukodystrophy (HP:0002415) | 2.30323152 |
| 46 | Gait imbalance (HP:0002141) | 2.27228494 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.25946370 |
| 48 | Neutropenia (HP:0001875) | 2.24360016 |
| 49 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.21474520 |
| 50 | Type I transferrin isoform profile (HP:0003642) | 2.20432861 |
| 51 | Lethargy (HP:0001254) | 2.19978214 |
| 52 | Ulnar claw (HP:0001178) | 2.18243103 |
| 53 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.17470581 |
| 54 | Increased hepatocellular lipid droplets (HP:0006565) | 2.16278008 |
| 55 | Methylmalonic aciduria (HP:0012120) | 2.16271951 |
| 56 | Methylmalonic acidemia (HP:0002912) | 2.08539489 |
| 57 | Bile duct proliferation (HP:0001408) | 2.07477468 |
| 58 | Abnormal biliary tract physiology (HP:0012439) | 2.07477468 |
| 59 | Renal Fanconi syndrome (HP:0001994) | 2.04155956 |
| 60 | Delayed CNS myelination (HP:0002188) | 2.03236679 |
| 61 | Fatigable weakness (HP:0003473) | 2.02011410 |
| 62 | Abnormality of the neuromuscular junction (HP:0003398) | 2.02011410 |
| 63 | Tubular atrophy (HP:0000092) | 2.01978597 |
| 64 | Abnormality of the renal medulla (HP:0100957) | 2.01943050 |
| 65 | Abnormality of the renal cortex (HP:0011035) | 2.00603984 |
| 66 | Cone-rod dystrophy (HP:0000548) | 1.97260768 |
| 67 | Exercise intolerance (HP:0003546) | 1.95969596 |
| 68 | Nephronophthisis (HP:0000090) | 1.93890058 |
| 69 | True hermaphroditism (HP:0010459) | 1.92295203 |
| 70 | Increased intramyocellular lipid droplets (HP:0012240) | 1.92227250 |
| 71 | Pheochromocytoma (HP:0002666) | 1.90999058 |
| 72 | Microvesicular hepatic steatosis (HP:0001414) | 1.89819241 |
| 73 | Cerebral hemorrhage (HP:0001342) | 1.87065810 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 1.85888846 |
| 75 | Bilateral microphthalmos (HP:0007633) | 1.85842323 |
| 76 | Dicarboxylic aciduria (HP:0003215) | 1.85499731 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.85499731 |
| 78 | Renal cortical cysts (HP:0000803) | 1.80114878 |
| 79 | Abnormality of lateral ventricle (HP:0030047) | 1.76935155 |
| 80 | Keratoconjunctivitis (HP:0001096) | 1.76253113 |
| 81 | Short tibia (HP:0005736) | 1.76116636 |
| 82 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75528316 |
| 83 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74982198 |
| 84 | Sensory axonal neuropathy (HP:0003390) | 1.73977657 |
| 85 | Tubulointerstitial fibrosis (HP:0005576) | 1.73526638 |
| 86 | Gaze-evoked nystagmus (HP:0000640) | 1.73422408 |
| 87 | Nausea (HP:0002018) | 1.73102590 |
| 88 | X-linked dominant inheritance (HP:0001423) | 1.71354463 |
| 89 | Blindness (HP:0000618) | 1.70886229 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 1.70702807 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 1.68544660 |
| 92 | Glycosuria (HP:0003076) | 1.68544660 |
| 93 | Genital tract atresia (HP:0001827) | 1.64903498 |
| 94 | Supernumerary spleens (HP:0009799) | 1.64701043 |
| 95 | Left ventricular hypertrophy (HP:0001712) | 1.62593879 |
| 96 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.62295598 |
| 97 | Abnormality of macular pigmentation (HP:0008002) | 1.61433300 |
| 98 | Increased muscle lipid content (HP:0009058) | 1.60690402 |
| 99 | Attenuation of retinal blood vessels (HP:0007843) | 1.59260119 |
| 100 | Hyperalaninemia (HP:0003348) | 1.56877507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 8.73900200 |
| 2 | EIF2AK3 | 3.26632077 |
| 3 | MAP3K12 | 2.99161022 |
| 4 | SIK3 | 2.81040839 |
| 5 | VRK1 | 2.75480776 |
| 6 | BMPR1B | 2.62494368 |
| 7 | FRK | 2.56879882 |
| 8 | TAF1 | 2.41785359 |
| 9 | NUAK1 | 2.40958931 |
| 10 | EIF2AK1 | 2.00053756 |
| 11 | MAP4K2 | 1.94688092 |
| 12 | MAPKAPK5 | 1.76233741 |
| 13 | MYLK | 1.64884725 |
| 14 | DAPK1 | 1.62538584 |
| 15 | GRK7 | 1.60180699 |
| 16 | PASK | 1.49335486 |
| 17 | GRK1 | 1.47021678 |
| 18 | TSSK6 | 1.44626552 |
| 19 | TRIM28 | 1.36782662 |
| 20 | MARK1 | 1.34669965 |
| 21 | KSR1 | 1.31630843 |
| 22 | PLK2 | 1.21624433 |
| 23 | CASK | 1.21527888 |
| 24 | MAP3K13 | 1.20994132 |
| 25 | TAOK3 | 1.20279777 |
| 26 | ADRBK2 | 1.19002924 |
| 27 | MST4 | 1.15269651 |
| 28 | PRKCG | 1.11399195 |
| 29 | SMG1 | 1.09834495 |
| 30 | MAP3K9 | 1.09643421 |
| 31 | GRK5 | 1.07518256 |
| 32 | STK16 | 1.06244082 |
| 33 | TGFBR1 | 1.04711502 |
| 34 | CDC7 | 1.04566644 |
| 35 | CDK8 | 1.03048313 |
| 36 | PLK3 | 0.99275046 |
| 37 | WNK3 | 0.98359650 |
| 38 | NTRK3 | 0.96731020 |
| 39 | PIK3CG | 0.91633059 |
| 40 | IRAK3 | 0.91272097 |
| 41 | MAPK4 | 0.88933668 |
| 42 | NME1 | 0.87398047 |
| 43 | MAP3K3 | 0.86983596 |
| 44 | FES | 0.84744092 |
| 45 | MAPKAPK3 | 0.83764102 |
| 46 | MAPK13 | 0.83558149 |
| 47 | DAPK3 | 0.81173101 |
| 48 | PDK2 | 0.80333490 |
| 49 | PINK1 | 0.78133058 |
| 50 | EPHA4 | 0.78123853 |
| 51 | NEK1 | 0.75826547 |
| 52 | BUB1 | 0.74408252 |
| 53 | DDR2 | 0.72741980 |
| 54 | DYRK2 | 0.72029824 |
| 55 | PAK3 | 0.70810609 |
| 56 | NEK9 | 0.69803388 |
| 57 | PRKCE | 0.69565563 |
| 58 | NME2 | 0.69365943 |
| 59 | ADRBK1 | 0.69204949 |
| 60 | STK39 | 0.64504793 |
| 61 | TESK2 | 0.59264902 |
| 62 | OXSR1 | 0.58088696 |
| 63 | CAMK2A | 0.53182830 |
| 64 | CAMK2G | 0.52499139 |
| 65 | GRK6 | 0.51673251 |
| 66 | CSNK1G1 | 0.49439927 |
| 67 | CSNK1G3 | 0.49412587 |
| 68 | MKNK1 | 0.43593085 |
| 69 | MARK3 | 0.43543298 |
| 70 | CDK6 | 0.41381380 |
| 71 | ARAF | 0.41238197 |
| 72 | DYRK3 | 0.41205055 |
| 73 | CLK1 | 0.40099418 |
| 74 | TIE1 | 0.39067576 |
| 75 | PLK1 | 0.38875043 |
| 76 | PAK6 | 0.37484021 |
| 77 | PRKCI | 0.36315973 |
| 78 | TRPM7 | 0.36124889 |
| 79 | CDK4 | 0.35941528 |
| 80 | KSR2 | 0.35882901 |
| 81 | KIT | 0.35254522 |
| 82 | MKNK2 | 0.34289882 |
| 83 | MAP3K11 | 0.34175229 |
| 84 | INSRR | 0.33513503 |
| 85 | EIF2AK2 | 0.33130755 |
| 86 | SRPK1 | 0.33039118 |
| 87 | TNIK | 0.32479834 |
| 88 | LIMK1 | 0.29418959 |
| 89 | GSK3A | 0.29381165 |
| 90 | PBK | 0.27213087 |
| 91 | RPS6KA5 | 0.27207511 |
| 92 | CSNK1G2 | 0.27167527 |
| 93 | PTK2B | 0.26201494 |
| 94 | KDR | 0.26092152 |
| 95 | CSNK1A1L | 0.25229584 |
| 96 | PRKACB | 0.25108599 |
| 97 | DYRK1A | 0.24681088 |
| 98 | TGFBR2 | 0.23387131 |
| 99 | CSNK2A1 | 0.23311690 |
| 100 | PRKAA2 | 0.22905642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.94713684 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.16929226 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.46900728 |
| 4 | Huntingtons disease_Homo sapiens_hsa05016 | 3.05698367 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.94339411 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.75377287 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.61787406 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.54046530 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.42150577 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.23432810 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.21207974 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.07137619 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.77214782 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 1.73703758 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.68272711 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.66963472 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.62472856 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.60755175 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.48373802 |
| 20 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.47417204 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.42881125 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41242431 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.36960275 |
| 24 | Purine metabolism_Homo sapiens_hsa00230 | 1.36186308 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.36022697 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.34743331 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.34228361 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.27938490 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26586532 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.25152246 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23146044 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22283974 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18811538 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16234804 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15463545 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15253422 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14312627 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13110132 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08169102 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.07117089 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06145886 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04917699 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02219554 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.91517402 |
| 45 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81588802 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76719518 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75762224 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73535309 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72024655 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71164288 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 0.68742061 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68452023 |
| 53 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67939042 |
| 54 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67281397 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64614679 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63955804 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63080960 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.63076571 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61742829 |
| 60 | Morphine addiction_Homo sapiens_hsa05032 | 0.59840106 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56594543 |
| 62 | Taste transduction_Homo sapiens_hsa04742 | 0.55914185 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55575416 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54780195 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54756947 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53906363 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53827370 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53610657 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52097107 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51843648 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51783210 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48681984 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45770463 |
| 74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43914693 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43606385 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41918453 |
| 77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41523056 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40990231 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.40421755 |
| 80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.39737442 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.38908049 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38830448 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.38773551 |
| 84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36514556 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36139478 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35462358 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35009676 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35000800 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.34747085 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34730804 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.34138237 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.33534117 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32183593 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32159950 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31716767 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31272648 |
| 97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.29262626 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25867036 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.24992702 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.24046121 |

